HLB bioStep Co.,Ltd. (KOSDAQ:278650)
1,272.00
0.00 (0.00%)
At close: Feb 19, 2026
HLB bioStep Market Cap
HLB bioStep has a market cap or net worth of 105.08 billion as of February 20, 2026. Its market cap has decreased by -45.38% in one year.
Market Cap
105.08B
Enterprise Value
116.39B
Revenue
71.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,272.00
Market Cap Chart
Since November 27, 2019, HLB bioStep's market cap has decreased from 254.44B to 105.08B, a decrease of -58.70%. That is a compound annual growth rate of -13.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 107.45B | -12.52% |
| Dec 30, 2025 | 122.82B | -30.37% |
| Dec 30, 2024 | 176.39B | -27.37% |
| Dec 28, 2023 | 242.88B | -25.95% |
| Dec 29, 2022 | 327.97B | 49.60% |
| Dec 30, 2021 | 219.23B | 14.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hyundai ADM Bio | 404.15B |
| DreamCIS | 141.81B |
| LabGenomics | 125.09B |
| P&K Skin Research Center | 69.32B |
| C&R Research | 51.44B |
| WOOJUNG BIO | 40.48B |
| DT&CRO CO. | 35.28B |
| SLS BIO | 26.89B |